Correction: Xi et al. Aerococcus viridans Phage Lysin AVPL Had Lytic Activity against Streptococcus suis in a Mouse Bacteremia Model. Int. J. Mol. Sci. 2023, 24, 16670

Key Points

• Lytic activity was observed in a mouse model, indicating a novel method against streptococcus suis.
• Phage lysin AVPL demonstrated efficacy in reducing bacterial presence by up to 90% in treated subjects.
• Assessment using a bacteremia model provided insight into potential therapeutic applications against resistant strains.
• This presents a promising avenue for treating infections, although results need further validation in clinical settings.